Oracle Shares Face Mounting Investor Anxiety Ahead of Earnings
05.12.2025 - 04:12:04Oracle US68389X1054
Oracle Corporation finds itself at a critical juncture, with its equity experiencing significant turbulence. As the market anticipates the company's quarterly results on December 10th, a clear divide has emerged among shareholders. Optimism surrounding a potential artificial intelligence-driven order boom is being tempered by growing concerns over the company's balance sheet and aggressive spending. While the long-term growth narrative remains compelling, immediate signals from the credit markets are urging caution.
All eyes are on Oracle's upcoming earnings release after the market closes this Wednesday. Investor focus will be intensely fixed on the company's remaining performance obligations (RPO), a key metric for future revenue. Widespread market speculation suggests a massive backlog, fueled by high-profile AI partnerships with firms including OpenAI and Microsoft. The executive team faces a challenging balancing act: they must convincingly articulate the substantial revenue potential of these contracts while simultaneously addressing worries about the cost of financing their expansion. A demonstration that this backlog can be profitably converted into cash flow while managing debt levels could shift sentiment positively. Conversely, any ambiguity regarding financial sustainability may trigger further volatility.
Credit Market Signals Flash Red
A particularly stark warning is currently emanating not from the equity market, but from the debt arena. The cost of insuring Oracle's bonds against default, known as Credit Default Swaps (CDS), has surged dramatically. Recent levels have reached heights not seen since the 2008/2009 financial crisis. This spike underscores creditor anxiety about the company's aggressive capital expenditure strategy. Oracle is investing billions to build out its artificial intelligence infrastructure, leading market observers to fear a drastic increase in net debt by 2028 if the current investment pace continues. Such credit market concerns traditionally exert downward pressure on stock valuations as well.
Should investors sell immediately? Or is it worth buying Oracle?
Analysts Adjust Targets Amid Rising Risks
Institutional investors and research firms are recalibrating their models to account for heightened financial risk. Citigroup notably reduced its price target for Oracle shares to $375 on Thursday, although it maintained its overall "Buy" recommendation. The analyst cited uncertainties surrounding the precise funding mechanisms for the company's substantial capital expenditures. While demand for AI solutions is acknowledged as robust, the near-term financial risks have undeniably increased due to the leverage situation. The stock remains under pressure, trading significantly below its recent peaks.
Key Data Points:
* Last Price: €184.10
* Distance from 52-Week High: -34.41%
* 30-Day Volatility: 41.00%
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from December 5 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 5.
Oracle: Buy or sell? Read more here...


